Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$161M |
| 2 |
Entergy
ETR
|
+$126M |
| 3 |
Danaher
DHR
|
+$124M |
| 4 |
Cooper Companies
COO
|
+$65.6M |
| 5 |
PPL
PPL Corp
PPL
|
+$61.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$419M |
| 2 |
CMS Energy
CMS
|
+$170M |
| 3 |
Duke Energy
DUK
|
+$164M |
| 4 |
Citigroup
C
|
+$124M |
| 5 |
Chevron
CVX
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.02% |
| 2 | Utilities | 9.78% |
| 3 | Financials | 9.29% |
| 4 | Technology | 8.37% |
| 5 | Consumer Discretionary | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRC
1126
Commerce.com Inc Series 1
CMRC
$186M
| $456K | ﹤0.01% |
79,208
-100,821
| -56% | -$641K |
|
1127
Aurinia Pharmaceuticals
AUPH
$2.2B
| $454K | ﹤0.01% |
56,500
+3,000
| +6% | +$24.3K |
|
1128
Bain Capital Specialty
BCSF
$786M
| $450K | ﹤0.01% |
+27,100
| New | +$477K |
|
|
FSUN
1129
FirstSun Capital Bancorp
FSUN
$1.78B
| $450K | ﹤0.01% |
+12,455
| New | +$496K |
|
|
PGRE
1130
DELISTED
Paramount Group
PGRE
| $448K | ﹤0.01% |
104,233
-7,063
| -6% | -$31.9K |
|
1131
Monte Rosa Therapeutics
GLUE
$1.18B
| $447K | ﹤0.01% |
+96,345
| New | +$591K |
|
1132
Golub Capital BDC
GBDC
$3.44B
| $445K | ﹤0.01% |
29,400
-51,375
| -64% | -$788K |
|
1133
Skyward Specialty Insurance
SKWD
$2.35B
| $445K | ﹤0.01% |
+8,400
| New | +$405K |
|
1134
Regenxbio
RGNX
$531M
| $444K | ﹤0.01% |
62,052
-43,616
| -41% | -$324K |
|
|
AAT
1135
American Assets Trust
AAT
$1.41B
| $443K | ﹤0.01% |
+22,011
| New | +$496K |
|
1136
Arvinas
ARVN
$611M
| $443K | ﹤0.01% |
+63,052
| New | +$988K |
|
|
LADR
1137
Ladder Capital
LADR
$1.27B
| $442K | ﹤0.01% |
+38,752
| New | +$443K |
|
1138
Dominari Holdings
DOMH
$62.8M
| $440K | ﹤0.01% |
+110,000
| New | +$525K |
|
1139
Health Catalyst
HCAT
$120M
| $440K | ﹤0.01% |
97,117
+82,003
| +543% | +$434K |
|
|
AVNS
1140
DELISTED
Avanos Medical
AVNS
| $436K | ﹤0.01% |
+30,418
| New | +$475K |
|
|
BECN
1141
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $434K | ﹤0.01% |
+3,506
| New | +$408K |
|
1142
Aptiv
APTV
$9.83B
| $433K | ﹤0.01% |
7,271
-31,423
| -81% | -$1.99M |
|
|
BFS
1143
Saul Centers
BFS
$844M
| $432K | ﹤0.01% |
11,970
+4,133
| +53% | +$151K |
|
|
VTLE
1144
DELISTED
Vital Energy
VTLE
| $427K | ﹤0.01% |
+20,125
| New | +$583K |
|
|
HONE
1145
DELISTED
HarborOne Bancorp
HONE
| $426K | ﹤0.01% |
41,049
+11,011
| +37% | +$126K |
|
1146
Amalgamated Financial
AMAL
$1.46B
| $425K | ﹤0.01% |
14,796
+325
| +2% | +$10.6K |
|
1147
Bank of Hawaii
BOH
$3.03B
| $425K | ﹤0.01% |
6,165
-61,187
| -91% | -$4.35M |
|
1148
Horizon Bancorp
HBNC
$1.01B
| $425K | ﹤0.01% |
28,200
+9,607
| +52% | +$156K |
|
1149
Payoneer
PAYO
$2.41B
| $425K | ﹤0.01% |
+58,164
| New | +$542K |
|
1150
York Water
YORW
$561M
| $423K | ﹤0.01% |
+12,207
| New | +$397K |
|
Similar funds
Michael Gelband's Q1 2025 Portfolio in Review
As of Q1 2025, Michael Gelband held 2,114 positions worth $10.1B, down 31% from $14.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Michael Gelband withdrew a net $3.98B in Q1 2025, closing 725 positions and reducing 350 holdings. Its most notable exit was CMS Energy, an estimated $170M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8% a quarter earlier, followed by Utilities and Financials.
Against the trend, Michael Gelband opened a new position in Ameren worth $168M.
- Michael Gelband's largest Q1 2025 buy was Ameren: 1,668,398 shares worth $168M.
- Michael Gelband added most to Danaher in Q1 2025, an estimated $124M increase.
- Michael Gelband's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $419M.
- Michael Gelband fully exited CMS Energy in Q1 2025, selling an estimated $170M.
- Michael Gelband's ten largest holdings make up 26% of its $10.1B portfolio in Q1 2025.
- Michael Gelband opened 677 new positions and closed 725 in Q1 2025.
- Michael Gelband's portfolio value fell 31% quarter-over-quarter to $10.1B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.